dabigatran has been researched along with Ureteral Obstruction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annaldas, S; Godugu, C; Saifi, MA | 1 |
1 other study(ies) available for dabigatran and Ureteral Obstruction
| Article | Year |
|---|---|
A direct thrombin inhibitor, dabigatran etexilate protects from renal fibrosis by inhibiting protease activated receptor-1.
Topics: Animals; Antithrombins; Collagen Type I; Dabigatran; Disease Models, Animal; Epithelial-Mesenchymal Transition; Fibrosis; Kidney; Kidney Diseases; Male; Mice; Oxidative Stress; Receptor, PAR-1; Signal Transduction; Snail Family Transcription Factors; Transforming Growth Factor beta; Ureteral Obstruction | 2021 |